Literature DB >> 27083924

Is there a role for salvage lymphadenectomy as second line therapy post robotic radical prostatectomy?

Sanchia Goonewardene1, D Cahill2.   

Abstract

Keywords:  Lymphadenectomy; Robotic radical prostatectomy; Salvage therapy

Mesh：

Substances：

Year:  2016        PMID： 27083924     DOI： 10.1007/s11701-016-0579-7

Source DB:  PubMed          Journal:  J Robot Surg        ISSN： 1863-2483


× No keyword cloud information.
  11 in total

Review 1.  Salvage lymphadenectomy in postprostatectomy patients with prostate-specific antigen recurrence.

Authors:  Nazareno Suardi; Alberto Briganti; Andrea Salonia; Patrizio Rigatti
Journal:  Curr Opin Urol       Date:  2011-05       Impact factor: 2.309

2.  Salvage lymph node dissection for biochemical recurrence following radical prostatectomy: is the evidence there?

Authors:  Ofer Yossepowitch
Journal:  Eur Urol       Date:  2014-05-02       Impact factor: 20.096

3.  Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography.

Authors:  S Hijazi; B Meller; C Leitsmann; A Strauss; J Meller; C O Ritter; J Lotz; H-U Schildhaus; L Trojan; C O Sahlmann
Journal:  Prostate       Date:  2015-09-10       Impact factor: 4.104

Review 4.  Pelvic lymph node dissection in prostate cancer.

Authors:  Alberto Briganti; Michael L Blute; James H Eastham; Markus Graefen; Axel Heidenreich; Jeffrey R Karnes; Francesco Montorsi; Urs E Studer
Journal:  Eur Urol       Date:  2009-03-10       Impact factor: 20.096

5.  11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.

Authors:  Riccardo Schiavina; Vincenzo Scattoni; Paolo Castellucci; Maria Picchio; Barbara Corti; Alberto Briganti; Alessandro Franceschelli; Francesco Sanguedolce; Alessandro Bertaccini; Moshen Farsad; Giampiero Giovacchini; Stefano Fanti; Walter Franco Grigioni; Ferruccio Fazio; Francesco Montorsi; Patrizio Rigatti; Giuseppe Martorana
Journal:  Eur Urol       Date:  2008-04-18       Impact factor: 20.096

6.  Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.

Authors:  David Schilling; Heinz P Schlemmer; Philipp H Wagner; Patrick Böttcher; Axel S Merseburger; Philip Aschoff; Roland Bares; Christa Pfannenberg; Ute Ganswindt; Stefan Corvin; Arnulf Stenzl
Journal:  BJU Int       Date:  2008-04-11       Impact factor: 5.588

7.  Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.

Authors:  Niccolò M Passoni; Nazareno Suardi; Firas Abdollah; Maria Picchio; Giampiero Giovacchini; Cristina Messa; Massimo Freschi; Francesco Montorsi; Alberto Briganti
Journal:  Urol Oncol       Date:  2013-06-13       Impact factor: 3.498

8.  Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.

Authors:  Martin T Freitag; Jan P Radtke; Boris A Hadaschik; A Kopp-Schneider; Matthias Eder; Klaus Kopka; Uwe Haberkorn; Matthias Roethke; Heinz-Peter Schlemmer; Ali Afshar-Oromieh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-28       Impact factor: 9.236

Review 9.  Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.

Authors:  Firas Abdollah; Alberto Briganti; Francesco Montorsi; Arnulf Stenzl; Christian Stief; Bertrand Tombal; Hein Van Poppel; Karim Touijer
Journal:  Eur Urol       Date:  2014-03-26       Impact factor: 20.096

10.  Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.

Authors:  Alexander Winter; Rolf-Peter Henke; Friedhelm Wawroschek
Journal:  BMC Urol       Date:  2015-02-21       Impact factor: 2.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.